Observational studyAdvances in therapy2024

Satisfaction with the Injection Experience of a New, Citrate-Free Formulation of Ixekizumab.

Sanjay Chabra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.